Description |
Product Type |
Product Size |
Syrup |
1'S |
Product Company |
Sami Pharmaceutical |
Lactitol monohydrate 120ml |
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Highnoon Lab |
Budesonide 400mcg, Formoterol 6mcg
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Pfizer
|
Carboplatin 150mg/15ml
|
Product Type |
Product Size |
Drops |
1'S |
Product Company |
ICI Pakistan |
Nystatin 50ml |
Product Type |
Product Size |
Tablet |
30'S |
Product Company |
Sanofi |
Furosemide and amiloride 5mg |
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Himmel Pharma
|
Carboplatin 150mg/15ml |
Content | Lactitol is an orally administered osmotic laxative used to treat chronic idiopathic constipation. | Combivair 400mcg/6mcg rotacapsule is composed of budesonide and formoterol This medication is used for treatment of coughing, wheezing, and tightness of chest caused by asthma.
| Carboplatin is a platinum-containing chemotherapy medicine, which belongs to the alkylating agents group of medicines. It is used to treat various cancers. It prevents growth of cancerous cells by damaging their DNA that aids in its proliferation.
| Nystatin is an antifungal medicine and not an antibiotic. It makes holes in the cell membrane of the fungus and the contents leak out. This kills the fungus and treats the infection. If you're taking nystatin to prevent an infection, the medicine kills any fungus as it starts to appear.
| A combination of Furosemide and Amiloride is a diuretic which reduces the potassium loss of furosemide alone while avoiding the possible gastro-intestinal disturbances of potassium supplements.
| Carboplatin is an alkylating agent used to treat advanced ovarian cancer.Carboplatin is indicated in combination with an established combination of chemotherapeutic agents for the initial treatment of advanced ovarian carcinoma. Carboplatin is also indicated for the palliative treatment of ovarian carcinoma, recurrent after prior chemotherapy.
|
Reviews
There are no reviews yet.